Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Pediatric Crohn's Disease (REACH)
NCT00207675Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2003
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in Crohn's disease, sponsored by Janssen Pharmaceutical. Started Feb 2003; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00207675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207675.